Publication | Open Access
Randomized controlled trial of deutetrabenazine for tardive dyskinesia
322
Citations
14
References
2017
Year
This study provides Class I evidence that in patients with TD, deutetrabenazine reduces AIMS scores.
| Year | Citations | |
|---|---|---|
Page 1
Page 1